REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,412 | -47.0% | 18,083 | +17.0% | 0.00% | -50.0% |
| Q2 2023 | $391,318 | -15.2% | 15,461 | +7.9% | 0.00% | 0.0% |
| Q1 2023 | $461,473 | +80.2% | 14,327 | +3.3% | 0.00% | +100.0% |
| Q4 2022 | $256,059 | +20.2% | 13,871 | +76.0% | 0.00% | 0.0% |
| Q3 2022 | $213,000 | +95.4% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $109,000 | -29.2% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $154,000 | +19.4% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $129,000 | -41.4% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $220,000 | -6.0% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | +6.4% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $220,000 | -1.3% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | +12.6% | 7,882 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $198,000 | +3.1% | 7,882 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $192,000 | +242.9% | 7,882 | +107.0% | 0.00% | +100.0% |
| Q1 2020 | $56,000 | +27.3% | 3,807 | +39.6% | 0.00% | – |
| Q4 2019 | $44,000 | +25.7% | 2,727 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | +84.2% | 2,727 | +86.1% | 0.00% | – |
| Q2 2019 | $19,000 | -17.4% | 1,465 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | -51.1% | 1,465 | -37.7% | 0.00% | – |
| Q4 2018 | $47,000 | +56.7% | 2,352 | +97.2% | 0.00% | – |
| Q3 2018 | $30,000 | -9.1% | 1,193 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | -10.8% | 1,193 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -14.0% | 1,193 | 0.0% | 0.00% | – |
| Q4 2017 | $43,000 | +330.0% | 1,193 | +213.9% | 0.00% | – |
| Q3 2017 | $10,000 | 0.0% | 380 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | +25.0% | 380 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | 0.0% | 380 | 0.0% | 0.00% | – |
| Q4 2016 | $8,000 | +33.3% | 380 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +20.0% | 380 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -28.6% | 380 | 0.0% | 0.00% | – |
| Q1 2016 | $7,000 | -46.2% | 380 | 0.0% | 0.00% | – |
| Q4 2015 | $13,000 | +18.2% | 380 | 0.0% | 0.00% | – |
| Q3 2015 | $11,000 | -99.8% | 380 | -99.7% | 0.00% | -100.0% |
| Q2 2014 | $4,420,000 | +40.3% | 130,000 | +30.0% | 0.13% | +34.0% |
| Q1 2014 | $3,150,000 | – | 100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |